GlassScriptPhysician profile
Christopher Maull
NPI 1356301840
$5,036.16
in general payments reported to CMS, 2019-2025
42 companies · $1,217 in 2025
The $1,217 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $534 · 2020: $260 · 2021: $306 · 2022: $965 · 2023: $492 · 2024: $1,263 · 2025: $1,217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,926 · Education: $45.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,925.91 |
| Education | $45.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $676.69 | 2022-2025 | Jelmyto |
| Boston Scientific Corporation | $422.79 | 2020-2025 | Rezum Generator, Spaceoar Vue System - 10ml, Greenlight Xps |
| Dendreon Pharmaceuticals LLC | $340.18 | 2019-2025 | Provenge |
| Teleflex LLC | $324.67 | 2021-2024 | Urolift |
| Astellas Pharma US INC | $236.23 | 2019-2023 | Myrbetriq |
| Janssen Biotech, INC. | $213.49 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $209.21 | 2024-2025 | Orgovyx, Gemtesa |
| Abbvie INC. | $181.09 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $172.47 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Pfizer INC. | $158.35 | 2019-2024 | |
| C. R. Bard, INC. & Subsidiaries | $157.31 | 2025 | Bard Urinary Drainage Bag |
| Myriad Genetic Laboratories, INC. | $144.52 | 2022-2025 | Prolaris |
| Neotract INC. | $144.50 | 2019-2020 | |
| Progenics Pharmaceuticals, INC. | $122.95 | 2022-2025 | |
| Tolmar, INC. | $117.26 | 2023-2025 | Jatenzo, Eligard |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $116.96 | 2019-2022 | |
| 180 Medical, INC. | $112.09 | 2021-2023 | Gentlecath |
| Ferring Pharmaceuticals INC. | $105.47 | 2019-2025 | Adstiladrin |
| Bayer Healthcare Pharmaceuticals INC. | $97.67 | 2022-2025 | |
| Endo USA, INC. | $86.09 | 2024-2025 | Xiaflex, Aveed |
| Amgen INC. | $85.83 | 2019-2022 | |
| Blue Earth Diagnostics | $77.05 | 2023-2024 | |
| Endo Pharmaceuticals INC. | $73.55 | 2019-2024 | Xiaflex, Aveed |
| Procept Biorobotics Corporation | $63.60 | 2023-2024 | Aquabeam Robotic System, Aquabeam System |
| Laborie Medical Technologies Corp. | $59.24 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Telix Pharmaceuticals | $58.00 | 2024-2025 | Illuccix |
| Bioprotect Medical, INC. | $50.48 | 2025 | Bioprotect Balloon Implant System |
| Astrazeneca Pharmaceuticals LP | $48.07 | 2020-2025 | Imfinzi |
| Myovant Sciences INC. | $42.71 | 2021-2022 | |
| Immunitybio, INC. | $42.57 | 2025 | |
| Cardinal Health 414 LLC | $40.00 | 2025 | |
| Tolmar Pharmaceuticals, INC. | $38.85 | 2019-2022 | |
| Inspire Medical Systems, INC. | $38.78 | 2024 | Inspire |
| Olympus America INC. | $29.06 | 2023 | Itind System |
| Verity Pharmaceuticals INC. | $23.99 | 2025 | Tlando |
| Axogen | $23.24 | 2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Ha+ Nerve Protector |
| Palette Life Sciences, INC. | $19.83 | 2023 | |
| Dentsply Ih Ab | $19.66 | 2024 | Lofric |
| Civco Medical Instruments | $16.90 | 2025 | |
| Novartis Pharmaceuticals Corporation | $16.52 | 2025 | |
| Photocure INC | $14.65 | 2021 | |
| Hollister Incorporated | $13.59 | 2023 | Vapro, Onli, Infyna Chic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Maull listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.